• Inside Pfizer's palace coup

    Inside Pfizer's palace coup

    Did CEO Jeff Kindler get pushed out because he was shaking up the dysfunctional pharmaceutical giant -- or because he's an ineffective leader?

  • China: The next biotech superpower?

    China will spend billions on biotech, even as the industry struggles in the U.S. to turn research into gold. Will U.S. biotech become the next Detroit?

  • Allergan's survival strategy: Botox everlasting

    A huge part of Allergan's patent-cliff immunity against other big pharmaceuticals is its blockbuster Botox, which has helped the company evade the patent problems facing others in the industry.

  • The war over Lipitor

    India's Ranbaxy won the right to make a generic version of the $11 billion drug -- only to be accused of seri ous fraud and shoddy practices in another case. Now a fight is erupting over the mega-popular cholesterol medication.

Latest Galleries
Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.